| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/12/2005 | EP1228043B1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 01/12/2005 | EP1183254B1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 01/12/2005 | EP0893442B1 Lymph-absorbable imidazole derivatives |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1564687A Use of phosphodiesterase IV inhibitors |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1563005A Ramification in albocarbon category and application in anoxia system |
| 01/12/2005 | CN1562999A Compound of biindole heterocycles, preparation method and application in use for organic electroluminescence material |
| 01/12/2005 | CN1562970A PPAR full activator of amino acids of aralkyl possessing excellent activity for lowering sugar and ester |
| 01/12/2005 | CN1184221C New quinalidinic acid derivative with 7-(7-aminomethyl-5-azaspiro [2,4] heplane) substituent and its preparation method |
| 01/12/2005 | CN1184215C Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators |
| 01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
| 01/12/2005 | CN1184207C Process for producing insecticide intermediate |
| 01/12/2005 | CN1184206C Prepn process of pyrazole derivative |
| 01/12/2005 | CN1184204C Piperidine compounds for use as CCR-3 inhibitors |
| 01/12/2005 | CN1183907C Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/11/2005 | US6841563 Aryloxy propanolamines for improving livestock production |
| 01/11/2005 | US6841562 Treatment of gram positive and staphylococcic infections |
| 01/11/2005 | US6841560 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/11/2005 | US6841555 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 01/11/2005 | US6841552 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disorders |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2241244C Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation |
| 01/11/2005 | CA2104909C Decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 01/06/2005 | WO2005000836A1 Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 01/06/2005 | WO2005000835A1 Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines |
| 01/06/2005 | WO2005000822A1 N-{‘4-substituted piperazine-1-sulfonylmethyl!alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | WO2005000821A1 Tachykinin receptor antagonists |
| 01/06/2005 | WO2005000820A2 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists |
| 01/06/2005 | WO2005000818A1 5-substituted-4-`(substituted phenyl)!amino!-2-pyridone deviatives for use as mek inhibitors |
| 01/06/2005 | WO2005000817A2 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 01/06/2005 | WO2005000813A1 Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors |
| 01/06/2005 | WO2005000811A1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 01/06/2005 | WO2005000809A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 01/06/2005 | WO2005000804A2 Substituted indoles and a process for preparing substituted indoles |
| 01/06/2005 | WO2005000404A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 01/06/2005 | WO2005000232A2 Six membered amino-amide derivatives as angiogenesis inhibitors |
| 01/06/2005 | WO2004101528A3 Isoquinoline derivatives and their use as gfat inhibitors |
| 01/06/2005 | WO2004087646A3 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | WO1999044608A8 New use |
| 01/06/2005 | US20050004369 Phenyl substituted carboxylic acids |
| 01/06/2005 | US20050004367 Sulfonamide derivatives |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |
| 01/06/2005 | US20050004230 Retroviral protease inhibitors |
| 01/06/2005 | US20050004205 Such as 1-[N alpha -(1'-Acetoxyethoxycarbonyl)-N omega -(pyrazinyl-2-carbonyl)-L-ornithinyl]-pyrrolidine-2-carbonitrile; impaired glucose tolerance, type II diabetes, hypoglycaemia |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004202 Such as 3-[1-(3-methoxypropyl )-1H-indazol-3-yl]-4-[1-(3-pyridinyl )-1H-indol-3-yl]-1H-pyrrole-2,5-dione; protein kinase C and/or glycogen synthase kinase-3 diseases |
| 01/06/2005 | US20050004201 Cardiovascular and inflammatory diseases; immunological, dermatological, oncological and central nervous system disorders; diabetes and associated disorders; protein kinase C and glycogen synthase kinase-3 |
| 01/06/2005 | US20050004200 Pyrazole compounds as integrin receptor antagonists derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004176 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/06/2005 | US20050004175 Xanthine oxidase inhibitors; hyperuricemia and gout; such as 3-(4-isobutoxy-3-nitrophenyl)-5-(2-methyl-4-pyridyl)-1,2,4-triazole |
| 01/06/2005 | US20050004172 Solvent free hexacoordinated octahedral form N; acetone solvate forms A3, A4, hexacoordinated octahedral A1 and pentacoordinated square pyramidal A2; methyl acetate solvate forms B2, B3 and hexacoordinated octahedral B1; methylethyl ketone solvate forms C2 and hexacoordinated octahedral C1; desolvated E1 |
| 01/06/2005 | US20050004170 Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage |
| 01/06/2005 | US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004151 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| 01/06/2005 | US20050004149 Pyrimidine compound and medicinal composition thereof |
| 01/06/2005 | US20050004143 Bi-cyclic pyrimidine inhibitors of TGFbeta |
| 01/06/2005 | US20050004140 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 01/06/2005 | US20050004136 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful as neurokinin receptor modulators |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004129 Pyrazole derivatives |
| 01/06/2005 | US20050004127 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004125 Such as 4-[[4-(1-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]-benzonitrile; bipolar disorder, pain, type 2 diabetes |
| 01/06/2005 | US20050004124 Synergistic mixture; antidiabetic agents; antiischemic agents |
| 01/06/2005 | US20050004122 Such as 1(R)-{2,2-Dimethyl-3(R)-[1-(3,4-dichlorophenyl)-3-pyridin-3-yl-1H-pyrazol-5-yl ]cyclobutyl}acetic acid; farnesyl-protein transferase and geranylgeranyl-protein transferase inhibitors |
| 01/06/2005 | US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004117 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004114 Heterocycle substituted carboxylic acids |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/06/2005 | US20050004111 Degenerative joints disease; osteoarthritis |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004103 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/06/2005 | US20050004097 Indole derivatives |
| 01/06/2005 | US20050004042 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 01/06/2005 | US20050002986 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 01/06/2005 | CA2530142A1 Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines |
| 01/06/2005 | CA2529468A1 N-{[4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | CA2529353A1 Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 01/06/2005 | CA2529227A1 Benzodiazepine cgrp receptor antagonists |
| 01/06/2005 | CA2528619A1 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 01/06/2005 | CA2527079A1 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 01/06/2005 | CA2526988A1 Substituted indoles and a process for preparing substituted indoles |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |